Published in Br J Cancer on September 11, 2014
Metastatic basal cell carcinoma: a frequent disease with rare clinical evolution. BMJ Case Rep (2015) 0.79
Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder. Pharmaceut Med (2017) 0.75
A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma. J Skin Cancer (2017) 0.75
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med (2009) 8.55
Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med (2012) 6.90
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol (2013) 4.75
Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol (2008) 4.60
A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol (2012) 4.57
Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med (2012) 4.19
Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2010) 2.80
Guidelines for the management of basal cell carcinoma. Br J Dermatol (2008) 2.57
Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol (1989) 2.14
Basal cell carcinoma. BMJ (2003) 2.10
Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor. J Invest Dermatol (2011) 1.98
Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol (1992) 1.94
Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol (2002) 1.81
Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer (1997) 1.74
Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol (2005) 1.56
Facial basal cell carcinoma. BMJ (2012) 1.41
Nonmelanoma skin cancer. J Cutan Aesthet Surg (2012) 1.40
Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg (2005) 1.35
Hedgehog pathway as a drug target: Smoothened inhibitors in development. Onco Targets Ther (2012) 1.27
Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors. Clin Cancer Res (2013) 1.25
Oral hedgehog-pathway inhibitors for basal-cell carcinoma. N Engl J Med (2012) 1.19
Roles of the immune system in skin cancer. Br J Dermatol (2011) 1.12
Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer (2003) 1.06
Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature. J Cutan Pathol (2012) 1.05
Genetic skin diseases predisposing to basal cell carcinoma. Eur J Dermatol (2012) 1.02
Giant basal cell carcinoma of the skin: literature review and personal experience. J Eur Acad Dermatol Venereol (2011) 0.91
Giant and large basal cell carcinoma treated with topical photodynamic therapy. Eur J Dermatol (2008) 0.84
The National Comprehensive Cancer Network (NCCN) guidelines of care for nonmelanoma skin cancers. Dermatol Surg (2000) 0.83
Assessing current treatment options for patients with severe/advanced basal cell carcinoma. Semin Cutan Med Surg (2011) 0.81
Treating basal-cell carcinoma in a real life setting. Lancet Oncol (2013) 0.78
Nevoid basal cell carcinoma syndrome. Dermatol Online J (2011) 0.78
Molecular signatures linked with aggressive behavior in basal cell carcinoma: a report of 6 cases. Am J Dermatopathol (2010) 0.77